Sami Hawwa

Life Sciences Growth Equity Investor

📍 United States🔄 Updated September 2026💼 6 investments📅 5 years investing🗓 Last invested Jul 2026
VC🌍 United StatesInvested this quarter
6
Total investments
0
Early stage
0
Mid stage
3
Late stage
5y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jul 2026
At CAI, we are a professional services firm designed to accelerate operational readiness and excellence in critical environments. Our team of engineering, quality, and operations experts combines top-tier talent with the latest technology to deliver projects on time and within budget. Were committed to continuous improvement, real connections, and the highest standards, aiming to lead the industry and build the future. Are you ready?
Investor
Feb 2024
Improve yield, reduce deviations, and ensure product quality in GxP pharmaceutical manufacturing with real-time, practical Artificial Intelligence (AI)- powered software as a service solutions.
Board Observer
Feb 2024
For us, life science manufacturing isn’t a routine of formulation, mixing, dispensing, labeling, kitting, and packaging. It’s our priority. Our experience in each manufacturing stage complements your team and is applied to your product. From product launch to scale-up to re-vitalization, we can help at each stage in your product life cycle. Like you, we are makers. Make the call and let’s discuss the right solution for your product (888) 834-8892 info@argonautms.com
Investor
Feb 2023
Beaconcure supports biopharmaceutical companies and CROs with Verify, a secure online workspace for AI-enabled clinical study analysis validation. Designed in partnership with trusted large pharmaceutical companies and used in an increasing number of approved products, Verify streamlines validation workflows, reduces error rates, and increases efficiency compared to traditional processes. Beaconcure is revolutionizing the way new drugs and vaccines are approved for market by replacing manual processes with deep tech. Accurate analysis of clinical research data is critical to helping millions of people receive safe and effective medical treatments faster, and Verify provides assurance that these analyses are of the highest integrity. In June 2023, Beaconcure raised $14 million in Series B financing. By working at Beaconcure, you can reshape and impact the speed at which new medications aid patients, many of whom may be your family or friends. You will also help drive the translation of meaningful ideas into beneficial products with the support of an inclusive and diverse group of highly talented professionals. View open positions here: https://www.comeet.com/jobs/beaconcure/E8.004 #machinelearning #AI #statisticalanalysis #regulatorysubmission #clinicaltrial #dataintegrity
Experience · 8 entries
All (8)
Investments (6)
Board (4)
2026
Board Observer
Jul 2026
At CAI, we are a professional services firm designed to accelerate operational readiness and excellence in critical environments. Our team of engineering, quality, and operations experts combines top-tier talent with the latest technology to deliver projects on time and within budget. Were committed to continuous improvement, real connections, and the highest standards, aiming to lead the industry and build the future. Are you ready?
2025
Board Member
Sep 2025
Noxilizer, Inc. provides ultra-low temperature (10°C to 30°C) nitrogen dioxide sterilization technology that offers many benefits over traditional sterilization methods. Noxilizer sells sterilization equipment to pharmaceutical, biotech and medical device manufacturers and also offers contract sterilization services at its Baltimore, MD facilities. Noxilizer’s expert microbiology and material compatibility team is ready to partner to solve sterilization challenges through every phase of the process. To learn more about Noxilizer’s contract sterilization services or sterilization equipment please email info@noxilizer.com or visit www.noxilizer.com
2024
Principal
Sep 2024
Founded in 2022, NewVale Capital is a growth equity investment firm focused on supporting the services architecture underpinning the life science industry. The firm invests in proven, revenue-generating services businesses across the life science ecosystem that are helping to bring the next generation of medicines to patients.
Investor
Feb 2024
Improve yield, reduce deviations, and ensure product quality in GxP pharmaceutical manufacturing with real-time, practical Artificial Intelligence (AI)- powered software as a service solutions.
Board Observer
Feb 2024
For us, life science manufacturing isn’t a routine of formulation, mixing, dispensing, labeling, kitting, and packaging. It’s our priority. Our experience in each manufacturing stage complements your team and is applied to your product. From product launch to scale-up to re-vitalization, we can help at each stage in your product life cycle. Like you, we are makers. Make the call and let’s discuss the right solution for your product (888) 834-8892 info@argonautms.com
Show all 8 entries ↓
Investment activity
2021–2026 · 6 investments
2021120231202422025120261
Recent (last 2 years)Earlier